<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AMedical_stop-loss_insurance</id>
	<title>Definition:Medical stop-loss insurance - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AMedical_stop-loss_insurance"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Medical_stop-loss_insurance&amp;action=history"/>
	<updated>2026-04-30T05:49:45Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Medical_stop-loss_insurance&amp;diff=15820&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Medical_stop-loss_insurance&amp;diff=15820&amp;oldid=prev"/>
		<updated>2026-03-15T04:06:58Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;🛡️ &amp;#039;&amp;#039;&amp;#039;Medical stop-loss insurance&amp;#039;&amp;#039;&amp;#039; is a form of [[Definition:Reinsurance | reinsurance]]-like protection purchased by employers who [[Definition:Self-insurance | self-fund]] their employee health benefit plans, designed to cap the employer&amp;#039;s financial exposure when [[Definition:Claims | claims]] exceed predetermined thresholds. Because self-funded employers assume direct responsibility for paying employees&amp;#039; medical claims — rather than transferring that risk entirely to a [[Definition:Health insurance | health insurer]] — stop-loss coverage serves as a financial safety net against catastrophic or unexpectedly high aggregate claims. The product is most prevalent in the United States, where a substantial share of large and mid-size employers self-fund their health plans under the framework of the Employee Retirement Income Security Act ([[Definition:ERISA | ERISA]]).&lt;br /&gt;
&lt;br /&gt;
⚙️ Stop-loss insurance operates through two complementary structures. [[Definition:Specific stop-loss | Specific stop-loss]] (also called individual stop-loss) reimburses the employer when any single covered individual&amp;#039;s claims exceed a specified [[Definition:Deductible | deductible]] — known as the specific attachment point — during the policy period. [[Definition:Aggregate stop-loss | Aggregate stop-loss]] protects against the total plan claims exceeding a predetermined corridor, typically calculated as a percentage of expected claims for the group. Once the aggregate attachment point is breached, the stop-loss carrier reimburses the employer for excess amounts up to the policy limit. [[Definition:Third-party administrator (TPA) | Third-party administrators]] usually handle day-to-day claims adjudication, while the stop-loss carrier monitors claims data and manages the reimbursement process. Pricing relies heavily on the employer&amp;#039;s historical claims experience, group demographics, plan design, and the specific and aggregate attachment points selected — with lower attachment points commanding significantly higher [[Definition:Premium | premiums]].&lt;br /&gt;
&lt;br /&gt;
📊 The medical stop-loss market has grown substantially as self-funding has expanded beyond large corporations into the mid-market and even smaller employer segments, often facilitated by [[Definition:Professional employer organization (PEO) | PEOs]], [[Definition:Association health plan | association health plans]], and [[Definition:Insurtech | insurtech]] platforms that make self-funding operationally accessible. For [[Definition:Insurance carrier | carriers]] and [[Definition:Managing general agent (MGA) | MGAs]] operating in this space, the challenge lies in accurately modeling [[Definition:Large loss | large-loss]] frequency and severity in an environment of rapidly rising specialty drug costs and high-cost medical therapies such as gene therapy. Stop-loss underwriting increasingly leverages [[Definition:Predictive analytics | predictive analytics]] and [[Definition:Data analytics | claims data]] platforms to identify groups with embedded high-cost claimants. While medical stop-loss is fundamentally a U.S. product tied to the American employer-sponsored health system, analogous concepts exist in other markets — for instance, large-deductible [[Definition:Group health insurance | group health]] arrangements in parts of Europe and Asia may incorporate similar excess-of-loss protections, though the regulatory and structural frameworks differ considerably.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Self-insurance]]&lt;br /&gt;
* [[Definition:Specific stop-loss]]&lt;br /&gt;
* [[Definition:Aggregate stop-loss]]&lt;br /&gt;
* [[Definition:Third-party administrator (TPA)]]&lt;br /&gt;
* [[Definition:Excess-of-loss reinsurance]]&lt;br /&gt;
* [[Definition:Group health insurance]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>